Advertisement
Australia markets closed
  • ALL ORDS

    7,837.40
    -100.10 (-1.26%)
     
  • ASX 200

    7,575.90
    -107.10 (-1.39%)
     
  • AUD/USD

    0.6542
    +0.0019 (+0.29%)
     
  • OIL

    83.94
    +0.37 (+0.44%)
     
  • GOLD

    2,354.20
    +11.70 (+0.50%)
     
  • Bitcoin AUD

    98,438.09
    +1,261.23 (+1.30%)
     
  • CMC Crypto 200

    1,383.71
    -12.82 (-0.95%)
     
  • AUD/EUR

    0.6111
    +0.0037 (+0.62%)
     
  • AUD/NZD

    1.0988
    +0.0030 (+0.27%)
     
  • NZX 50

    11,805.09
    -141.34 (-1.18%)
     
  • NASDAQ

    17,689.40
    +258.90 (+1.49%)
     
  • FTSE

    8,133.36
    +54.50 (+0.67%)
     
  • Dow Jones

    38,287.98
    +202.18 (+0.53%)
     
  • DAX

    18,161.30
    +244.02 (+1.36%)
     
  • Hang Seng

    17,651.15
    +366.61 (+2.12%)
     
  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     

Aptinyx Inc. (APTX) Q1 2022 Earnings Call Transcript

Aptinyx Inc. (APTX) Q1 2022 Earnings Call Transcript

On today's call, Andy Kidd, our president and chief executive officer, will discuss our business and clinical development progress; then Ashish Khanna, our chief financial officer and chief business officer, will review our financial results. Please see the forward-looking statement disclaimer in our financial results release issued this afternoon and the risk factors in the company's current and subsequent filings with the SEC.